MedPath
TGA Approval

AVTOZMA tocilizumab (rch) 400 mg/20 mL injection concentrated vial (444943)

444943

AVTOZMA tocilizumab (rch) 400 mg/20 mL injection concentrated vial

Celltrion Healthcare Australia Pty Ltd

May 30, 2025

Medicine

Medicine

Active

Registered - Prescription Injectable

Active Ingredients

Tocilizumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AVTOZMA tocilizumab (rch) 400 mg/20 mL injection concentrated vial (444943) - TGA 批准文号 | MedPath